Pelican BioThermal Commits to Support Diabetes Research and Awareness

Pelican BioThermal, the global name in cold chain, announces a company-wide philanthropic initiative to support diabetes awareness and research.

According to the American Diabetes Association, 29.1 million Americans (nearly 10% of the U.S. population) have diabetes and as many as 1.25 million of those have type 1 diabetes, requiring daily doses of insulin. The drug is not only costly, with prices rising steadily over the past decade, but to remain effective, insulin vials must also be kept cool—a challenge that Pelican BioThermal regularly addresses.

“Our products, including the Crēdo Cube™, are uniquely suited to maintain the temperature stability necessary to transport vital diabetic drugs. However, meeting temperature requirements for these drugs is only one component of an overall global health issue,” explained Adam Tetz, director of worldwide marketing at Pelican BioThermal. “Contributing to research and raising awareness about diabetes, a condition which affects more than 400 million people worldwide, is critical.”

Over the last year, Pelican BioThermal has participated in events with the American Diabetes Association, including participation in and sponsorship of the 2017 Twin Cities Tour de Cure, the organization’s premier cycling fundraising event.

The temperature controlled packaging leader also partnered with “For A Piece Of Cake,” a cycling challenge undertaken by riders Chiara Ricciardi and Riccardo Rocchi to help raise awareness of diabetes. Over the last year, Ricciardi, who has type 1 diabetes, and Riccardo covered a total of nearly 11,185 miles from Cesena, Italy to Singapore via bicycles. To maintain temperature stability of Ricciardi’s vital diabetic drugs, Pelican BioThermal supplied the pair with their Crēdo™ ProMed, a robust, temperature controlled portable medical transport bag designed for emergency first responders and medical couriers to ensure delicate pharmaceuticals remain safely intact.